$0.00639
-59.77-99.99%
Last update: Nov 4, 3:52 PM
EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (EVFM) Stock Price, Quote, News & History
EVFMOTCID
Evofem Biosciences Inc's (OTC: EVFM) recently completed the Phase 3 EVOGUARD trial evaluating Phexxi vaginal gel (EVO100) to prevent chlamydia and gonorrhea...
You can purchase shares of EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (OTCID:EVFM) through any online brokerage.
There are no as such competitors for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc..
There is no analysis for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. to provide a consensus price target.
The stock price for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. (OTCID: EVFM) is $0.00639 last updated November 4, 2026 at 3:52 PM EST.
There are no upcoming dividends for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc..
EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc..
EVOFEM BIOSCIENCE INC by Evofem Biosciences, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCID.
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and...
